1-10 of 10
Kai Hubel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tafasitamab Plus Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma: Results from a Phase 3 Study (inMIND)

Laurie H. Sehn, Stefano Luminari, Christian W. Scholz, Kai Hübel, Antonio Salar, Shankara Paneesha, Bjorn E Wahlin, Panayiotis Panayiotidis, Hui-Peng Lee, Ana Jiménez Ubieto, Juan-Manuel Sancho, Tae Min Kim, Eva Domingo Domenech, Takahiro Kumode, Christina Poh, Catherine Thieblemont, Dries Deeren, Edwin de Wit, Michael Arbushites, Marie-Laure Casadebaig, Marek Trneny
Journal: Blood
Blood (2024) 144 (Supplement 2): LBA-1.
https://doi.org/10.1182/blood-2024-212970
Published: 2024
Journal Articles

A promising step for high-risk FL

Clinical Trials & Observations
Kai Hübel
Journal: Blood
Blood (2024) 143 (17): 1679–1681.
https://doi.org/10.1182/blood.2023023686
Published: 2024
Journal Articles

The Addition of Rituximab to Cyclophosphamide, Doxorubicine, Vincristine and Prednisone (CHOP) Prolongs Overall Survival in Previously Untreated Mantle Cell Lymphoma: A Long Term Pooled Trials Analysis

Luca Fischer, Linmiao Jiang, Joerg Bittenbring, Kai Hübel, Christian Schmidt, Johannes Duell, Bernd Metzner, Jürgen Krauter, Bertram Glass, Andreas Hüttmann, Kerstin Schaefer-Eckart, Wolfram Klapper, Wolfgang Hiddemann, Michael Unterhalt, Martin H. Dreyling, Eva Hoster
Journal: Blood
Blood (2021) 138 (Supplement 1): 3551.
https://doi.org/10.1182/blood-2021-148074
Published: 2021
Journal Articles

Obinutuzumab Short Duration Infusion Is Preferred By Healthcare Providers and Has Minimal Impact on Patient-Reported Symptoms Among Patients with Untreated, Advanced Follicular Lymphoma

Peter Trask, Jaisson Bortolini, Shinya Rai, Antonio Salar, Miguel Canales, Dirk Klingbiel, Joana Parreira, Maud Deraet, Ekaterina Vorozheikina, Kai Hübel, Thomas Buchholz
Journal: Blood
Blood (2021) 138 (Supplement 1): 1345.
https://doi.org/10.1182/blood-2021-147911
Published: 2021
Journal Articles

Addition of High-Dose Cytarabine to Immunochemotherapy before Autologous Stem-Cell Transplantation in Patients Aged 65 Years or Younger with Mantle Cell Lymphoma (MCL Younger): A Long-Term Follow-up of the Randomized, Open-Label, Phase 3 Trial of the European Mantle Cell Lymphoma Network

Olivier Hermine, Linmiao Jiang, Jan Walewski, Andre Bosly, Michal Szymczyk, Catherine Thieblemont, Christiane Pott, Gilles Salles, Pierre Feugier, Kai Hübel, Barbara Burroni, Wolfram Klapper, Michael Unterhalt, Eva Hoster, Martin Dreyling
Journal: Blood
Blood (2021) 138 (Supplement 1): 380.
https://doi.org/10.1182/blood-2021-150181
Published: 2021
Journal Articles

Ongoing Study of Obinutuzumab Short Duration Infusion in Patients with Previously Untreated Advanced Follicular Lymphoma

Miguel A Canales, MD PhD, Thomas A Buchholz, MD, James R Mason, MD, Joana M Parreira, MD, Monique S Tomiczek, MSc, Kai Hübel, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5269.
https://doi.org/10.1182/blood-2019-123638
Published: 2019
Journal Articles

Multi-Center Quantification Study of Time, Effort and Resource Utilization Associated with Autologous Peripheral Blood Stem Cell Mobilization: A European Perspective

Kai Hübel, MD, Nabih Azar, MD, David Dunning, MD, John Reitan, PharmD, Meghan E. Gallagher, MSc, Mohamad Mohty
Journal: Blood
Blood (2015) 126 (23): 2087.
https://doi.org/10.1182/blood.V126.23.2087.2087
Published: 2015
Journal Articles

Reduced Intensity Vs. Standard Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with MDS or Secondary AML: A Prospective, Randomized Phase III Study of the Chronic Malignancies Working Party of the EBMT (RICMAC-Trial)

Nicolaus Kröger, MD, Ronald Brand, PhD, Dietger Niederwieser, MD, Uwe Platzbecker, MD, Kai Hübel, MD, Thomas Weber, MD, Marie Robin, MD PhD, Matthias Stelljes, MD, Boris V Afanasiev, MD, Dominik Heim, MD, Giorgio Lambertenghi Deliliers, MD, Francesco Onida, MD, Peter Dreger, MD, Massimo Pini, MD, Stefano Guidi, Liisa Volin, MD, Martin Gramatzki, MD, Wolfgang A. Bethge, MD, Xavier Poire, MD, Guido Kobbe, MD, Marleen van Os, Simona Iacobelli, Theo de Witte, MD
Journal: Blood
Blood (2014) 124 (21): 320.
https://doi.org/10.1182/blood.V124.21.320.320
Published: 2014
Journal Articles

Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy

Clinical Trials & Observations
Christian Straka, Michael Sandherr, Hans Salwender, Hannes Wandt, Bernd Metzner, Kai Hübel, Gerda Silling, Marcus Hentrich, Daniel Franke, Rainer Schwerdtfeger, Mathias Freund, Orhan Sezer, Alexander Giagounidis, Gerhard Ehninger, Wolfgang Grimminger, Andreas Engert, Günter Schlimok, Christof Scheid, Peter Hellmann, Harald Heinisch, Hermann Einsele, Axel Hinke, Bertold Emmerich
Journal: Blood
Blood (2011) 117 (7): 2121–2128.
https://doi.org/10.1182/blood-2010-06-290080
Published: 2011
Journal Articles

Steady State Mobilization of Autologous Blood Stem Cells Using G-CSF and AMD3100 in Patients with Multiple Myeloma (MM).

Gerhard Ehninger, Stefan Fruehauf, Kai Hubel, Uwe Platzbecker, Karin Badel, Gary Calandra
Journal: Blood
Blood (2006) 108 (11): 5219.
https://doi.org/10.1182/blood.V108.11.5219.5219
Published: 2006